Tania A Stallons

Title: Tania A Stallons: Innovator in Cancer Treatment

Introduction

Tania A Stallons is a prominent inventor based in Wylie, TX (US). She has made significant contributions to the field of cancer treatment through her innovative research and development. Her work focuses on targeting cancer cells that overexpress somatostatin receptors, which is crucial for advancing therapeutic options in oncology.

Latest Patents

Tania A Stallons holds a patent for her invention titled "Treatment of cancer cells overexpressing somatostatin receptors using ocreotide derivatives." This patent describes a cancer-targeting composition, kit, and method for treating cancer cells that overexpress somatostatin receptors. The composition includes a radioisotope, a chelator, and a targeting moiety. The chelator features a nitrogen ring structure that includes a tetraazacyclododecane, a triazacyclononane, and/or a tetraazabicyclo [6.6.2] hexadecane derivative. The targeting moiety consists of a somatostatin receptor targeting peptide, which includes an octreotide derivative. This innovative approach allows for the targeted elimination of cancer cells.

Career Highlights

Throughout her career, Tania has worked with notable companies in the medical field, including Radiomedix Inc. and Orano Med. Her experience in these organizations has contributed to her expertise in developing advanced cancer treatment methodologies.

Collaborations

Tania A Stallons has collaborated with talented professionals in her field, including Izabela Tworowska and Nilesh Wagh. These collaborations have further enhanced her research and development efforts in cancer treatment.

Conclusion

Tania A Stallons is a dedicated inventor whose work in cancer treatment showcases her commitment to improving patient outcomes. Her innovative patent and collaborations highlight her significant contributions to the medical field.